Skip to main navigation
Logo

Investors

Press Releases

Press Releases

  • All
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2016
May 26, 2022
Adicet Bio Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory Non-Hodgkin’s Lymphoma (NHL)
May 18, 2022
Adicet Bio to Present at Upcoming Investor Conferences
May 12, 2022
Adicet Reports First Quarter 2022 Financial Results and Provides Business Updates
May 5, 2022
Adicet Presents Preclinical Data at the ISCT Annual Meeting Highlighting Potential Advantages of the Non-Gene-Edited Approach for its Investigational Allogeneic Gamma Delta CAR T Cell Therapy Targeting CD20 for B Cell Malignancies
May 4, 2022
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 27, 2022
Adicet Bio Announces Oral Presentation of Updated ADI-001 Phase 1 Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
April 19, 2022
Adicet Bio Receives FDA Fast Track Designation for Lead Candidate ADI-001
April 7, 2022
Adicet Bio to Participate in Upcoming Investor Conferences
April 1, 2022
Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2022
Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 68

Tools

  • Print
    Print
  • Email Alerts
    Email Alerts
  • Investor Contacts
    Investor Contacts

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
    • Stock Quote & Chart
    • Analyst Coverage
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts

Adicet - Header Navigation

  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Gamma Delta T Cells
    • Targeting Moieties
    • Proprietary Cell Platform
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Presentations and Publications
  • Investors
    • Overview
    • Press Releases
    • Presentations & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Careers
    • Join Our Team
    • Current Openings
  • Contact

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts
Logo © 2022 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.